Figueroa Casas P R, Badano A R, Miechi H R, Mirkin A
Reproduccion. 1975 Apr-Jun;2(2):141-6.
Thirthy one infertile women with different forms of anovulation were treated with LH-RH on various schemes of application: continuous intravenous (i.v.) infusion, intramuscular (i.m.) unique injection, continuous i.v. infusión plus i.m. unique injection, repeated i.v. injection, repeated i.m. injection and estrogens plus unique i.m. injection. On 46 cycles treated, ovulation was obtained in 18 (39.1%), 13 patients ovulated at least one cycle (41.8%) and six became pregnant (19.3%) three during the treatment and three during the first cycle post-treatment. The best results were obtained (63.2%) of ovulation) with the repeated i.v. injection scheme. Though the results obtained with LH-RH in relation to pregnancies, are lower than those obtained with other therapies of anovulation, the fact that we have been sucessful in cases on which other therapies of anovulation had been unsuccessful, the report up to now of only one case of mild ovary hyperestimulation, and the recent development of LH-RH analogs of more powerful and longer action, justifies the continuing of therpeutic assays with this hormone as to find the most effective scheme to induce ovulation.
31名患有不同形式无排卵症的不孕妇女接受了促黄体生成素释放激素(LH-RH)治疗,采用了多种应用方案:持续静脉输注、单次肌肉注射、持续静脉输注加单次肌肉注射、重复静脉注射、重复肌肉注射以及雌激素加单次肌肉注射。在46个治疗周期中,18例(39.1%)出现排卵,13名患者至少有一个周期排卵(41.8%),6例怀孕(19.3%),其中3例在治疗期间怀孕,3例在治疗后的第一个周期怀孕。重复静脉注射方案获得了最佳的排卵结果(63.2%)。尽管LH-RH在妊娠方面取得的结果低于其他无排卵治疗方法所取得的结果,但我们在其他无排卵治疗方法失败的病例中取得了成功,到目前为止仅报告了1例轻度卵巢过度刺激病例,以及最近开发出作用更强、持续时间更长的LH-RH类似物,这些都证明继续用这种激素进行治疗试验以找到诱导排卵的最有效方案是合理的。